1. Home
  2. ANGI vs PROK Comparison

ANGI vs PROK Comparison

Compare ANGI & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$7.18

Market Cap

266.7M

ML Signal

HOLD

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.82

Market Cap

296.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGI
PROK
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.7M
296.8M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
ANGI
PROK
Price
$7.18
$1.82
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$17.00
$7.40
AVG Volume (30 Days)
652.3K
973.1K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
1242.86
N/A
EPS
0.94
N/A
Revenue
$736,386,000.00
$893,000.00
Revenue This Year
$3.25
N/A
Revenue Next Year
$3.76
N/A
P/E Ratio
$7.91
N/A
Revenue Growth
47.60
1075.00
52 Week Low
$6.43
$0.54
52 Week High
$19.42
$7.13

Technical Indicators

Market Signals
Indicator
ANGI
PROK
Relative Strength Index (RSI) 44.45 41.55
Support Level $6.60 $1.71
Resistance Level $8.03 $2.58
Average True Range (ATR) 0.41 0.12
MACD 0.06 -0.01
Stochastic Oscillator 34.09 15.91

Price Performance

Historical Comparison
ANGI
PROK

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: